BIO
Bio-Rad Laboratories margins
- Stocks
- Healthcare
- NYSE: BIO
- Margins
At present, Bio-Rad Laboratories currently has a gross margin of 51.3%, an operating margin of -2.4%, an EBITDA margin of 52.8%, and a net margin of 39.5%; its operating margin is negative at -2.4%. The strongest positive change was in EBITDA margin, higher by 83.8 percentage points. The strongest negative change was in operating margin, lower by 11.2 percentage points.
BIO margin history
Bio-Rad Laboratories's margins averaged 52.88% gross, 7.62% operating, -19.66% EBITDA, and -17.1% net during the last 3 years. Against the three-year averages, EBITDA and net margins are above their three-year averages and gross and operating margins are below their three-year averages.
BIO margin expansion
The strongest improvement was in EBITDA margin, which increased by 83.8 percentage points, and net margin also expanded by 65.9 percentage points, whereas gross margin contracted by 1 percentage point and operating margin by 11.2 percentage points.
BIO Gross margin
Looking back over the last 3 years, Bio-Rad Laboratories recorded an average gross margin of 52.88%. Bio-Rad Laboratories's current gross margin is 51.3% and is 1.6 percentage points below its three-year average. The highest gross margin for Bio-Rad Laboratories was 54.4% in Sep 2024, while the lowest was 51.3% in Sep 2026.
BIO Operating margin
Over the last 3 years, the average operating margin for Bio-Rad Laboratories was 7.62%. The current operating margin stands at -2.4%, 10 percentage points below its three-year average. Bio-Rad Laboratories's operating margin ranged from a low of -2.4% in Sep 2026 to a high of 13% in Jun 2024.
BIO EBITDA margin
Bio-Rad Laboratories recorded an average EBITDA margin of -19.66% across the last 3 years. Bio-Rad Laboratories currently reports an EBITDA margin of 52.8%, 72.5 percentage points above its three-year average. Looking back over the last 3 years, Bio-Rad Laboratories's EBITDA margin reached 52.8% at its highest point in Sep 2026 and -106.3% at its lowest in Mar 2025.
BIO Net margin
Over the last 3 years, Bio-Rad Laboratories's net margin averaged -17.1%. Right now, Bio-Rad Laboratories's current net margin is 39.5%, which is 56.6 percentage points above its three-year average. During this period, net margin reached a high of 39.5% in Sep 2026 and a low of -85.2% in Mar 2025.
BIO margin group comparison
With a gross margin of 51.3%, BIO ranks lower than the Healthcare sector, the industry and its peers average. In comparison with the Healthcare sector average of 68.3%, Bio-Rad Laboratories's gross margin is 25% lower.
BIO margin peer comparison
Frequently asked questions
What is Bio-Rad Laboratories's gross margin?
As of Sep 30, 2026, BIO has a gross margin of 51.3%.
What is Bio-Rad Laboratories's operating margin?
For the period ending Sep 30, 2026, BIO recorded an operating margin of -2.4%.
What is Bio-Rad Laboratories's EBITDA margin?
The current EBITDA margin for BIO is 52.8% as of Sep 30, 2026.
What is Bio-Rad Laboratories's net margin?
As of Sep 30, 2026, BIO has a net margin of 39.5%.
What are the average margins of BIO?
Looking back over 3 years, BIO recorded average margins of 52.9% gross, 7.6% operating, -19.7% EBITDA, and -17.1% net.
What are the highest historical margins of BIO?
Within the 5-year period, BIO recorded its highest margins at 56.9% gross in Jun 2022, 18.9% operating in Jun 2022, 186.5% EBITDA in Dec 2021, and 145.6% net in Dec 2021.
What are the lowest historical margins of BIO?
Within the 5-year period, BIO recorded its lowest margins at 51.3% gross in Sep 2026, -2.4% operating in Sep 2026, -278% EBITDA in Sep 2022, and -214.7% net in Sep 2022.